Obstet Gynecol Sci.  2023 Nov;66(6):484-497. 10.5468/ogs.22288.

Patient blood management to minimize transfusions during the postpartum period

• Song KH
• Choi ES
• Kim HY
• Ahn KH
• Kim HJ

• KMID: 2547850
• DOI: http://doi.org/10.5468/ogs.22288

Abstract

Patient blood management is an evidence-based concept that seeks to minimize blood loss by maintaining adequate hemoglobin levels and optimizing hemostasis during surgery. Since the coronavirus disease 2019 pandemic, patient blood management has gained significance due to fewer blood donations and reduced amounts of blood stored for transfusion. Recently, the prevalence of postpartum hemorrhage (PPH), as well as the frequency of PPH-associated transfusions, has steadily increased. Therefore, proper blood transfusion is required to minimize PPH-associated complications while saving the patient’s life. Several guidelines have attempted to apply this concept to minimize anemia during pregnancy and bleeding during delivery, prevent bleeding after delivery, and optimize recovery methods from anemia. This study systematically reviewed various guidelines to determine blood loss management in pregnant women.

Keyword

Patient blood management; Postpartum hemorrhage; Blood transfusion; Pregnancy; Anemia; Bleeding

Figure

• 

  Fig. 1 Changes in adequacy of transfusion in PPH after PBM. Information from reference [41]. PPH, prevalence of postpartum hemorrhage; PBM, patient blood management.

Reference

References

1. Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol. 2017; 130:e168–86.

2. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2:e323–33.

3. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009; 9:55.

4. Kumaraswami S, Butwick A. Latest advances in postpartum hemorrhage management. Best Pract Res Clin Anaesthesiol. 2022; 36:123–34.

5. Alexander J, Thomas P, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database Syst Rev. 2002; 1:CD002867.

6. Likis FE, Sathe NA, Morgans AK, Hartmann KE, Young JL, Carlson-Bremer D, et al. Management of postpartum hemorrhage [Internet]. Rockville (MD): Agency for Healthcare Research and Quality;c2015. [cited 2022 Sep 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK294465/#!po=10.0000 .

7. Evensen A, Anderson JM, Fontaine P. Postpartum hemorrhage: prevention and treatment. Am Fam Physician. 2017; 95:442–9.

8. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010; 110:1368–73.

9. Pacagnella RC, Souza JP, Durocher J, Perel P, Blum J, Winikoff B, et al. A systematic review of the relationship between blood loss and clinical signs. PLoS One. 2013; 8:e57594.

10. Muñoz M, Stensballe J, Ducloy-Bouthors AS, Bonnet MP, De Robertis E, Fornet I, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A nata consensus statement. Blood Transfus. 2019; 17:112–36.

11. Prevention and management of postpartum haemorrhage: green-top guideline no. 52. BJOG. 2017; 124:e106–49.

12. National Institute for Health and Care Excellence. Intrapartum care for healthy women and babies [Internet]. Manchester (MAN): National Institute for Health and Care Excellence;c2017. [cited 2020 Sep 29]. Available from: https://www.nice.org.uk/guidance/cg190 .

13. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J. 2005; 98:419–22.

14. Bateman BT, Tsen LC, Liu J, Butwick AJ, Huybrechts KF. Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007–2011. Anesth Analg. 2014; 119:1344–9.

15. Patacchiola F, D’Alfonso A, Di Fonso A, Di Febbo G, Kaliakoudas D, Carta G. Intrauterine balloon tamponade as management of postpartum haemorrhage and prevention of haemorrhage related to low-lying placenta. Clin Exp Obstet Gynecol. 2012; 39:498–9.

16. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997; 104:372–5.

17. Waters JH, Bonnet MP. When and how should I transfuse during obstetric hemorrhage? Int J Obstet Anesth. 2021; 46:102973.

18. Kuklina EV, Meikle SF, Jamieson DJ, Whiteman MK, Barfield WD, Hillis SD, et al. Severe obstetric morbidity in the United States: 1998–2005. Obstet Gynecol. 2009; 113(2 Pt 1):293–9.

19. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010; 202:353.e1–6.

20. Mehrabadi A, Hutcheon JA, Lee L, Liston RM, Joseph KS. Trends in postpartum hemorrhage from 2000 to 2009: a population-based study. BMC Pregnancy Childbirth. 2012; 12:108.

21. Jakobsson M, Gissler M, Tapper AM. Risk factors for blood transfusion at delivery in Finland. Acta Obstet Gynecol Scand. 2013; 92:414–20.

22. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012; 119:306–14.

23. Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012; 120:1029–36.

24. Ouh YT, Lee KM, Ahn KH, Hong SC, Oh MJ, Kim HJ, et al. Predicting peripartum blood transfusion: focusing on pre-pregnancy characteristics. BMC Pregnancy Childbirth. 2019; 19:477.

25. Thomson A, Farmer S, Hofmann A, Isbister J, Shander A. Patient blood management - a new paradigm for transfusion medicine? ISBT Sci Ser. 2009; 4:423–35.

26. Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012; 116:1367–76.

27. Veseli B, Sandner S, Studte S, Clement M. The impact of COVID-19 on blood donations. PLoS One. 2022; 17:e0265171.

28. Shander A, Isbister J, Gombotz H. Patient blood management: the global view. Transfusion. 2016; 56(Suppl 1):S94–102.

29. World Health Organization. The clinical use of blood in medicine, obstetrics, paediatrics, surgery and anaesthesia, trauma and burns [Internet]. Geneva: World Health Organization;c2001. [cited 2022 Sep 29]. Available from: https://apps.who.int/iris/handle/10665/42397 .

30. Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion. 2015; 55:2807–15.

31. Gross I, Seifert B, Hofmann A, Spahn DR. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion. 2015; 55:1075–81.

32. Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion. 2014; 54:2753–9.

33. Keding V, Zacharowski K, Bechstein WO, Meybohm P, Schnitzbauer AA. Patient blood management improves outcome in oncologic surgery. World J Surg Oncol. 2018; 16:159.

34. Meybohm P, Richards T, Isbister J, Hofmann A, Shander A, Goodnough LT, et al. Patient blood management bundles to facilitate implementation. Transfus Med Rev. 2017; 31:62–71.

35. Theusinger OM, Kind SL, Seifert B, Borgeat L, Gerber C, Spahn DR. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus. 2014; 12:195–203.

36. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017; 57:1347–58.

37. Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, et al. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014; 54(10 Pt 2):2678–86.

38. Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, et al. Increased hospital costs associated with red blood cell transfusion. Transfusion. 2015; 55:1082–9.

39. Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg. 2019; 269:794–804.

40. World Health Organization. Availability, safety and quality of blood products [Internet]. Geneva: World Health Organization;c2010. [cited 2022 Sep 29]. Available from: https://apps.who.int/iris/handle/10665/3086 .

41. Shin HJ, Kim JH, Park Y, Ahn KH, Jung JS, Park JH. Effect of patient blood management system and feedback programme on appropriateness of transfusion: an experience of Asia’s first Bloodless Medicine Center on a hospital basis. Transfus Med. 2021; 31:55–62.

42. Hofmann A, Spahn DR, Holtorf AP. Making patient blood management the new norm(al) as experienced by implementors in diverse countries. BMC Health Serv Res. 2021; 21:634.

43. Surbek D, Vial Y, Girard T, Breymann C, Bencaiova GA, Baud D, et al. Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion. Arch Gynecol Obstet. 2020; 301:627–41.

44. World Health Organization. Worldwide prevalence of anaemia 1993–2005. WHO global database on anaemia [Internet]. Geneva: World Health Organization;c2008. [cited 2022 Sep 29]. Available from: https://apps.who.int/iris/handle/10665/43894 .

45. Ickx BE. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol. 2010; 27:1031–5.

46. Hytten F. Blood volume changes in normal pregnancy. Clin Haematol. 1985; 14:601–12.

47. Harstad TW, Mason RA, Cox SM. Serum erythropoietin quantitation in pregnancy using an enzyme-linked immunoassay. Am J Perinatol. 1992; 9:233–5.

48. Palihawadana TS, Goonewardene IMR, Motha MBC, Williams HSA. Iron deficiency anaemia in pregnancy: diagnosis, prevention and treatment. SLJOG. 2014; 36:61–5.

49. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013; 1:e16–25.

50. American College of Obstetricians and Gynecologists. Anemia in pregnancy: ACOG practice bulletin, number 233. Obstet Gynecol. 2021; 138:e55–64.

51. National Institute for Health and Care Excellence. Antenatal care [Internet]. Manchester (MAN): National Institute for Health and Care Excellence;c2021. [cited 2022 Sep 29]. Available from: https://www.nice.org.uk/guidance/ng201 .

52. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience [Internet]. Geneva: World Health Organization;c2016. [cited 2022 Sep 29]. Available from: https://www.who.int/publications/i/item/9789241549912 .

53. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012; 156:588–600.

54. Breymann C, Honegger C, Hösli I, Surbek D. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Arch Gynecol Obstet. 2017; 296:1229–34.

55. Recommendations to prevent and control iron deficiency in the United States. Centers for disease control and prevention. MMWR Recomm Rep. 1998; 47:1–29.

56. Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2012; 12:CD004736.

57. Froessler B, Gajic T, Dekker G, Hodyl NA. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Arch Gynecol Obstet. 2018; 298:75–82.

58. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth. 2014; 14:115.

59. Muñoz M, Peña-Rosas JP, Robinson S, Milman N, Holzgreve W, Breymann C, et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: nata consensus statement. Transfus Med. 2018; 28:22–39.

60. Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2019; CD007412.

61. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine massage for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2013; 2013:CD006431.

62. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004; 2004:CD000201.

63. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012; 2012:CD000494.

64. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage [Internet]. Geneva: World Health Organization;c2012. [cited 2022 Sep 29]. Available from: https://www.who.int/publications/i/item/9789241548502 .

65. Hofmeyr GJ, Mshweshwe NT, Gülmezoglu AM. Controlled cord traction for the third stage of labour. Cochrane Database Syst Rev. 2015; 1:CD008020.

66. Meshykhi LS, Nel MR, Lucas DN. The role of carbetocin in the prevention and management of postpartum haemorrhage. Int J Obstet Anesth. 2016; 28:61–9.

67. Briones JR, Talungchit P, Thavorncharoensap M, Chaikledkaew U. Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines. BMC Health Serv Res. 2020; 20:975.

68. Chao YS, McCormack S. Carbetocin for the prevention of post-partum hemorrhage: a review of clinical effectiveness, cost-effectiveness, and guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health;c2019. [cited 2023 July 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546425 .

69. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012; 344:e3054.

70. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011; 15:R117.

71. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemo- rrhage. Cochrane Database Syst Rev. 2014; 2014:CD003249.

72. Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. The WOMAN trial (World Maternal antifibrinolytic trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010; 11:40.

73. Lee HY, Shin JH, Kim J, Yoon HK, Ko GY, Won HS, et al. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology. 2012; 264:903–9.

74. Zwart JJ, Dijk PD, van Roosmalen J. Peripartum hysterectomy and arterial embolization for major obstetric hemorrhage: a 2-year nationwide cohort study in the Netherlands. Am J Obstet Gynecol. 2010; 202:150e1–7.

75. Soro MP, Denys A, de Rham M, Baud D. Short & long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review. Eur Radiol. 2017; 27:749–62.

76. O’Leary JL, O’Leary JA. Uterine artery ligation in the control of intractable postpartum hemorrhage. Am J Obstet Gynecol. 1966; 94:920–4.

77. O’Leary JL, O’Leary JA. Uterine artery ligation for control of postcesarean section hemorrhage. Obstet Gynecol. 1974; 43:849–53.

78. Doumouchtsis SK, Nikolopoulos K, Talaulikar V, Krishna A, Arulkumaran S. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG. 2014; 121:382–8.

79. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG. 2007; 114:356–61.

80. Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG. 2011; 118:856–64.

81. Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. Uterine compression sutures for the management of severe postpartum hemorrhage. Obstet Gynecol. 2011; 117:14–20.

82. Clyburn PA. Early thoughts on ’why mothers die 2000–2002’. Anaesthesia. 2004; 59:1157–9.

83. Lagrew D, McNulty J, Sakowski C, Cape V, McCormick E, Morton CH. Improving health care response to obstetric hemorrhage, a California Maternal Quality Care Collaborative toolkit [Internet]. Palo Alto: California Maternal Quality Care Collaborative;c2022. [cited 2022 Sep 29]. Available from: https://www.cmqcc.org/resources-tool-kits/toolkits/ob-hemorrhage-toolkit .

84. Shields LE, Smalarz K, Reffigee L, Mugg S, Burdumy TJ, Propst M. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol. 2011; 205:368.e1–8.

85. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007; 63:805–13.

86. Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma. 2009; 66:693–7.

87. Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol. 2015; 212:272–80.

88. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 2007; 47:1564–72.

89. Gutierrez MC, Goodnough LT, Druzin M, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth. 2012; 21:230–5.

90. Skupski DW, Lowenwirt IP, Weinbaum FI, Brodsky D, Danek M, Eglinton GS. Improving hospital systems for the care of women with major obstetric hemorrhage. Obstet Gynecol. 2006; 107:977–83.

91. Treml AB, Gorlin JB, Dutton RP, Scavone BM. Massive transfusion protocols: a survey of academic medical centers in the United States. Anesth Analg. 2017; 124:277–81.

92. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011; 51:338–43.

93. Teofili L, Bianchi M, Zanfini BA, Catarci S, Sicuranza R, Spartano S, et al. Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors. Mediterr J Hematol Infect Dis. 2014; 6:e2014069.

94. Reynolds BR, Forsythe RM, Harbrecht BG, Cuschieri J, Minei JP, Maier RV, et al. Hypothermia in massive transfusion: have we been paying enough attention to it? J Trauma Acute Care Surg. 2012; 73:486–91.

95. De Robertis E, Kozek-Langenecker SA, Tufano R, Romano GM, Piazza O, Zito Marinosci G. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol. 2015; 81:65–75.

96. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma. 2009; 67:202–8. discussion 208–9.

97. James AH, McLintock C, Lockhart E. Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol. 2012; 87(Suppl 1):S16–22.

98. Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012; 108:984–9.

99. de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011; 20:135–41.

100. Goucher H, Wong CA, Patel SK, Toledo P. Cell salvage in obstetrics. Anesth Analg. 2015; 121:465–8.

101. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion. 2011; 51:2244–56.

102. Murray D. Acute normovolemic hemodilution. Eur Spine J. 2004; 13(Suppl 1):S72–5.

103. Estella NM, Berry DL, Baker BW, Wali AT, Belfort MA. Normovolemic hemodilution before cesarean hysterectomy for placenta percreta. Obstet Gynecol. 1997; 90:669–70.

104. Nagy CJ, Wheeler AS, Archer TL. Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah’s Witness with placenta percreta. Int J Obstet Anesth. 2008; 17:159–63.

105. Pather S, Ford M, Reid R, Sykes P. Postpartum curettage: an audit of 200 cases. Aust N Z J Obstet Gynaecol. 2005; 45:368–71.

106. Royal College of Obstetricians and Gynaecologists. Bacterial sepsis following pregnancy (green-top guideline no. 64b) [Internet]. London: Royal College of Obstetricians and Gynaecologists;c2012. [cited 2022 Sep 29]. Available from: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/bacterial-sepsis-following-pregnancy-green-top-guideline-no-64b/ .

107. Nguyen M, Bendi VS, Guduru M, Olson E, Vivekanandan R, Foral PA, et al. Postpartum invasive group A streptococcus infection: case report and mini-review. Cureus. 2018; 10:e3184.

108. French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2004. (4):CD001067.

109. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30:270–382.

110. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol. 2011; 90:1247–53.

111. Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol. 2012; 91:143–54.

112. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW. Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol. 2010; 150:126–31.

113. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet. 2006; 93:220–4.

114. Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008; 87:949–59.

115. World Health Organization. Guideline: iron supplementation in postpartum women [Internet]. Geneva: World Health Organization;c2016. [cited 2022 Sep 29]. Available from: https://apps.who.int/iris/handle/10665/249242 .

116. Rathod S, Samal SK, Mahapatra PC, Samal S. Ferric carboxymaltose: a revolution in the treatment of postpartum anemia in Indian women. Int J Appl Basic Med Res. 2015; 5:25–30.